About
Neha Agarwal is a Senior Advisor at Adjuvant Capital, joining from PATH where she serves as Senior Director of Strategy. Her work focuses on market access and product introduction for health technologies—including vaccines, diagnostics, and medical devices—across low- and middle-income countries, working with governments, multilaterals, and industry. At Adjuvant she supports portfolio strategy, stakeholder engagement, and market-entry models for essential health products.
Invests in
BiotechDigital HealthImpact & Social GoodMedical Devices
Experience
- PATHSenior Director of Strategy, Office of the Presidentcurrent2025 — present
- PATHGlobal Program Co-Director, Diagnostics2022 — 2025San Francisco Bay Area
- PATHAssociate Director, Diagnostics2021 — 2022San Francisco Bay Area
- PATHSenior Market Access and Commercialization Officer, Diagnostics2018 — 2020
- PATHCommercialization Officer2016 — 2018
- Bay Area Global Health AllianceBoard Membercurrent2020 — presentSan Francisco Bay Area
- Clinton Health Access InitiativeMarket Access - TB Therapies2014 — 2015San Francisco Bay Area
- Applied Strategies ConsultingGlobal Health Strategy and Management2011 — 2014San Mateo
- Verinata Health (now Illumina)Process Development Engineer2009 — 2011
- Treatment Action GroupAdvocacy Reseacher and Writer2008 — 2009
- Columbia Technology VenturesIntern2007
- ALZA IncDesign Engineer2005 — 2006
Education
- University of California, BerkeleyBS, Bioengineering
- Columbia UniversityMS, Biomedical Engineering
Skills & more
Biotechnology23Medical Devices12Infectious Diseases21Lifesciences7R&D8Technology Transfer3Commercialization5Cross-functional Team Leadership5Life Sciences6Program Management5Market Entry2Strategic Planning4
+2 more
Market AssessmentsClinical ResearchFrom Neha's professional profile.
Same school
Also attended University of California, Berkeley863
Byron DeeterPartner at Bessemer Venture PartnersTrevor OelschigInvestment Team at General CatalystBrendan Bulik-SullivanInvestor at GV (Google Ventures)Glen AndersonPartner at Monta Vista CapitalAnthony LinHead of Intel Capital, Corporate Vice President at Intel CapitalScott ShawChief of Staff at Intel Capital
+ 857 more
Also attended Columbia University498
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)Erica VanInvestment Director at Intel Capital
+ 492 more
Shared employers
Also worked at PATH3
Also worked at Clinton Health Access Initiative17
Dan GebremedhinPartner at Flare Capital PartnersYashika ChoudharyInvestor at Powerhouse VenturesMia MorissetPrincipal at Inovia CapitalRyan NesbittGeneral Partner at Flori VenturesKaramveer AroraAssociate at Advent InternationalGaurav ManchandaChief Product Officer at MassChallenge Mexico
+ 11 more
Also worked at Columbia Technology Ventures19
Matthew McCooeChief Executive Officer at Connecticut InnovationsKristina VulganCo-Founder & Managing Partner at Ferocity CapitalLyla YoussefAssociate at SR One Capital ManagementMelissa FensterstockCompany Building Advisor at Material ImpactDave WechslerPrincipal at OMERS VenturesMicah KotchPartner at Blackhorn Ventures
+ 13 more
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
David Washer
Investor at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital


.jpeg)




























